IOL CHEMICALS & PHARM. | SURYA PHARMA | IOL CHEMICALS & PHARM./ SURYA PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.6 | 0.0 | 108,113.8% | View Chart |
P/BV | x | 1.5 | - | - | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. SURYA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SURYA PHARMA Mar-13 |
IOL CHEMICALS & PHARM./ SURYA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 12 | 4,399.2% | |
Low | Rs | 272 | 1 | 23,669.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 3.5 | 10,872.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | -13.4 | -176.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -10.7 | -296.2% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | -3.3 | -7,890.8% | |
Shares outstanding (eoy) | m | 58.71 | 248.05 | 23.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.9 | 55.7% | |
Avg P/E ratio | x | 17.1 | -0.5 | -3,428.6% | |
P/CF ratio (eoy) | x | 12.8 | -0.6 | -2,045.6% | |
Price / Book Value ratio | x | 1.6 | -2.1 | -76.8% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 1,656 | 1,434.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 139 | 1,207.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 862 | 2,573.5% | |
Other income | Rs m | 256 | 10 | 2,632.1% | |
Total revenues | Rs m | 22,427 | 871 | 2,574.1% | |
Gross profit | Rs m | 2,257 | -2,006 | -112.5% | |
Depreciation | Rs m | 462 | 683 | 67.5% | |
Interest | Rs m | 165 | 2,216 | 7.4% | |
Profit before tax | Rs m | 1,887 | -4,896 | -38.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -1,569 | -31.6% | |
Profit after tax | Rs m | 1,391 | -3,327 | -41.8% | |
Gross profit margin | % | 10.2 | -232.8 | -4.4% | |
Effective tax rate | % | 26.2 | 32.0 | 81.9% | |
Net profit margin | % | 6.3 | -386.1 | -1.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 9,911 | 97.5% | |
Current liabilities | Rs m | 5,025 | 18,404 | 27.3% | |
Net working cap to sales | % | 20.9 | -985.7 | -2.1% | |
Current ratio | x | 1.9 | 0.5 | 357.2% | |
Inventory Days | Days | 43 | 667 | 6.5% | |
Debtors Days | Days | 8 | 956,724,304 | 0.0% | |
Net fixed assets | Rs m | 11,017 | 9,029 | 122.0% | |
Share capital | Rs m | 587 | 248 | 236.7% | |
"Free" reserves | Rs m | 14,490 | -1,055 | -1,373.0% | |
Net worth | Rs m | 15,077 | -807 | -1,867.7% | |
Long term debt | Rs m | 0 | 3,841 | 0.0% | |
Total assets | Rs m | 20,684 | 18,941 | 109.2% | |
Interest coverage | x | 12.5 | -1.2 | -1,029.9% | |
Debt to equity ratio | x | 0 | -4.8 | -0.0% | |
Sales to assets ratio | x | 1.1 | 0 | 2,356.6% | |
Return on assets | % | 7.5 | -5.9 | -128.3% | |
Return on equity | % | 9.2 | 412.1 | 2.2% | |
Return on capital | % | 13.6 | -88.3 | -15.4% | |
Exports to sales | % | 26.7 | 24.2 | 110.5% | |
Imports to sales | % | 0 | 0.6 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 209 | 2,843.6% | |
Imports (cif) | Rs m | NA | 5 | 0.0% | |
Fx inflow | Rs m | 5,930 | 209 | 2,843.6% | |
Fx outflow | Rs m | 6,052 | 9 | 65,709.0% | |
Net fx | Rs m | -122 | 199 | -61.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 1,332 | 91.8% | |
From Investments | Rs m | -1,200 | -79 | 1,509.6% | |
From Financial Activity | Rs m | -41 | -1,331 | 3.1% | |
Net Cashflow | Rs m | -18 | -79 | 23.4% |
Indian Promoters | % | 48.2 | 1.0 | 5,019.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | 8,500.0% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 99.0 | 52.3% | |
Shareholders | 130,003 | 24,606 | 528.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SURYA PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.80% | -5.88% | 0.34% |
1-Month | 4.69% | -15.79% | 0.25% |
1-Year | -3.18% | -87.69% | 54.31% |
3-Year CAGR | -13.27% | -55.45% | 15.04% |
5-Year CAGR | 17.19% | -38.44% | 19.87% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SURYA PHARMA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SURYA PHARMA the stake stands at 1.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SURYA PHARMA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SURYA PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SURYA PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.